We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Novel Sequence Analysis Services Improve Pathogen Identification

By LabMedica International staff writers
Posted on 19 Nov 2014
Print article
A set of new-generation sequencing (NGS) services provides unique tools for more effective identification of known and unknown microorganisms, including bacterial, viral, fungal, and protozoan parasite pathogens.

Aperiomics (Ashburn, VA, USA) has now introduced its breakthrough Absolute-NGS Pathogen Detection Platform at the 2014 Annual Meeting of the Association for Molecular Pathology. The unique service addresses the biggest challenge in applying NGS to real-world analysis – making sense of the massive amount of data. Aperiomics, named after the Latin "aperio" meaning to reveal, is rolling out its platform package of 3 NGS services—Absolute-ID, Absolute-Discover, and Absolute-Biome—to provide better tools for rapid identification of known and unknown pathogens.

Absolute-ID is designed to identify known pathogens in virtually any sample. Absolute-Discover addresses the reality that many pathogens have not yet been discovered and many diseases are of unknown etiology. Pathogen identifications have historically been limited by what can be seen under a microscope and what can be cultured in a petri dish, but the Absolute-Discover service can discover new pathogens.

Absolute-Biome is designed to identify all microorganisms present in a given sample. Characterization of a microbial population, or microbiome, gives insight into the health of a human, animal, or environment. Such microbiome studies can be performed over space or time to study the impact of disease, drugs, or environmental changes in a complex system.

From a single test, innovative technology simultaneously tests for multiple pathogens using an unbiased sequencing and genomic analysis approach. The range of samples can include tissue, blood, plant, animal, or environmental. With a novel combination of genomics and informatics, Aperiomics has capitalized on high-throughput NGS and advanced Bayesian statistics to produce faster and better results than culture-based methods and even more accurate results than other molecular-based approaches.

Related Links:

Aperiomics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.